A higher Medicare Part B premium in 2026 could erode next year's cost-of-living adjustment for Social Security recipients, ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a ...

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

Medicare costs are surging in 2026, with Part B premiums jumping $18 monthly to $202.90. Guy Fieri details nasty on-set ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

Medicare costs are climbing in 2026, raising questions about whether supplemental coverage makes financial sense.

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.